Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
15.01
-0.07 (-0.46%)
At close: Jan 23, 2026, 4:00 PM EST
15.31
+0.30 (2.00%)
After-hours: Jan 23, 2026, 6:52 PM EST
Aardvark Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$31.11
Upside
+107.26%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $35 | Buy | Initiates | $35 | +133.18% | Dec 23, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +19.92% | Nov 14, 2025 |
| BTIG | BTIG | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +73.22% | Nov 7, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +119.85% | Oct 1, 2025 |
| Stifel | Stifel | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +59.89% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +166.49% | Sep 23, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $26 → $25 | Strong Buy | Maintains | $26 → $25 | +66.56% | Aug 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +26.58% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +166.49% | Jun 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +33.24% | May 15, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +39.91% | Apr 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +233.11% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $26 | Strong Buy | Maintains | $22 → $26 | +73.22% | Mar 27, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $21 | Buy | Initiates | $21 | +39.91% | Mar 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +233.11% | Mar 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.